Natraj Proteins Limited Dispatches KYC Compliance Letters to Physical Shareholders on May 9, 2026
Natraj Proteins Limited notified BSE Limited on May 9, 2026, that its RTA, M/s Ankit Consultancy Pvt. Ltd., has dispatched KYC letters to physical securities holders requiring PAN, nomination, contact details, bank account details, and specimen signature. The action is in compliance with multiple SEBI circulars, including the latest SEBI Circular HO/38/13/(4)2026-MIRSD-POD/I/4298/2026 dated February 06, 2026. Shareholders are reminded that effective April 1, 2024, all dividend, interest, and redemption payments for physical folios must be processed through electronic mode only. The filing was made under Regulation 30 of SEBI (LODR) Regulations, 2015.

*this image is generated using AI for illustrative purposes only.
Natraj Proteins Limited, a solvent extraction plant and refinery based in Itarsi, Madhya Pradesh, has notified BSE Limited of the dispatch of KYC compliance letters to its shareholders holding physical securities. The communication, filed on May 9, 2026, was submitted in compliance with Regulation 30 read with Schedule III Part A Para A Clause No. 12 of SEBI (LODR) Regulations, 2015.
KYC Dispatch and Regulatory Background
The company's Registrar and Share Transfer Agent (RTA), M/s Ankit Consultancy Pvt. Ltd., has dispatched letters to physical securities holders requesting mandatory submission of key KYC details. The dispatch is pursuant to SEBI circular dated November 03, 2021, subsequently amended by circulars dated December 14, 2021, March 16, 2023, November 17, 2023, and May 7, 2024, as well as SEBI Circular No. SEBI Circular HO/38/13/(4)2026-MIRSD-POD/I/4298/2026 dated February 06, 2026.
The following details are required from shareholders holding physical securities:
- PAN – Permanent Account Number
- Choice of Nomination – via Form SH-13, or opt-out via Form ISR-3
- Contact Details – Postal address with PIN and mobile number (via Form ISR-1)
- Bank Account Details – Bank and branch name, account number, and IFS code (via Form ISR-1)
- Specimen Signature – via Form ISR-2
Electronic Payment Mandate Effective April 1, 2024
Shareholders are advised that effective April 1, 2024, all payments including dividend, interest, or redemption in respect of physical folios shall be routed through electronic mode only. Folios that do not have PAN, KYC details, and Nomination updated will face restrictions on grievance lodging and service requests with the RTA until the required documents are furnished.
Submission Modes and RTA Contact Details
Shareholders may submit the required documents through any one of the following modes:
- In Person Verification (IPV): The authorized person of the RTA verifies original documents and retains copies with IPV stamping
- Hard copies: Self-attested and dated copies submitted directly
- Electronic mode: Submission with e-sign as elaborated under the SEBI circular
The relevant forms and SEBI circulars are available on the company's website and the RTA's website. Key form links are summarised below:
| Form: | Purpose |
|---|---|
| ISR-1 | Registration/updation of contact and bank details |
| ISR-2 | Specimen signature registration |
| ISR-3 | Declaration to opt out of nomination |
| SH-13 | Registration of nomination |
| SH-14 | Cancellation or variation of nomination |
| ISR-4 | Issuance of duplicate securities / other requests |
| ISR-5 | Transmission of securities |
The RTA contact details are as follows:
| Parameter: | Details |
|---|---|
| Name: | M/s Ankit Consultancy Pvt. Ltd. |
| Address: | 60, Electronic Complex, Pardeshipura, Indore (M.P.) - 452 010 |
| Telephone: | 0731-4065799, 4065797, 4949444 |
| Email: | investor@ankitonline.com |
| Website: | www.ankitonline.com |
The filing was signed by Harshita Kirkire, Company Secretary and Compliance Officer (M. No.: A77514), on behalf of Natraj Proteins Limited.
Historical Stock Returns for Natraj Proteins
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +6.83% | -1.99% | -1.73% | -4.31% | -8.46% | -19.77% |
What percentage of Natraj Proteins' physical securities holders are expected to remain non-compliant after the KYC deadline, and how might this affect the company's dividend distribution process?
How could SEBI's ongoing push to dematerialize physical securities impact smaller companies like Natraj Proteins in terms of shareholder base consolidation and administrative costs?
Will persistent non-compliance by physical folio holders potentially lead to SEBI mandating a complete freeze on trading or transfer of such securities in future regulatory updates?





























